First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Sees Strong Trading Volume – Time to Buy?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) shares saw unusually-strong trading volume on Monday . Approximately 76,999 shares were traded during mid-day trading, an increase of 283% from the previous session’s volume of 20,079 shares.The stock last traded at $201.91 and had previously closed at $199.85.

First Trust NYSE Arca Biotechnology Index Fund Price Performance

The firm has a market capitalization of $1.21 billion, a P/E ratio of 21.72 and a beta of 0.65. The business has a 50 day moving average price of $187.01 and a 200 day moving average price of $172.65.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

Hedge funds have recently bought and sold shares of the stock. Glassman Wealth Services bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the 1st quarter worth about $27,000. Russell Investments Group Ltd. raised its holdings in First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% in the 3rd quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after acquiring an additional 158 shares in the last quarter. Rossby Financial LCC lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 160.0% in the 3rd quarter. Rossby Financial LCC now owns 169 shares of the company’s stock worth $31,000 after acquiring an additional 104 shares during the period. Capital Investment Advisory Services LLC grew its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 63.1% during the 3rd quarter. Capital Investment Advisory Services LLC now owns 181 shares of the company’s stock worth $32,000 after purchasing an additional 70 shares in the last quarter. Finally, Hazlett Burt & Watson Inc. increased its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 101.0% during the third quarter. Hazlett Burt & Watson Inc. now owns 201 shares of the company’s stock valued at $36,000 after purchasing an additional 101 shares during the period.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.